January 2026

Join WhatsApp Channel 

Crack GPAT — Prepare for GPAT Online 
Fellowship Opening for Pharma Professionals at NIPER
6 January 2026

Fellowship Opportunity for Pharma Professionals at NIPER

M. Pharm. or M.S. Pharm. or M. Sc. with 1 year research experience or M. Tech. Strong Python programming skills with hands-on experience of using scientific Python libraries.
6 January 2026
Pharmacist Openings at AIIMS, RIMS and Central Coalfields Limited Hospitals
D.Pharm / B.Pharm Freshers can apply D.Pharm / B.Pharm with post qualification experience in retail pharmacy.
6 January 2026
Research Opportunities at All India Institute of Medical Sciences
Project Research Scientist-I under ICMR- funded project titled Evaluation of novel dipstick based molecular techniques for early detection of Gram- negative ESKAPE organisms and antimicrobial resistance genes in bum wounds.
6 January 2026
Career Opportunities in Parenteral QMS at Sun Pharma
Master of Pharmacy Participation in Investigations, Root cause analysis and proposing relevant CAPAs against OOS: OOT: incident, and change control complaints and audit observations to QMS team.
6 January 2026
Hetero hiring professionals in the Formulation Quality Control, ARD, Production & Packing department
Hetero is one of worlds leading producers of key Active Pharmaceutical Ingredients (APIs) and generic formulations with presence in 140 countries and backed by 30 years of experience in the pharma sector.
6 January 2026
Torrent Pharmaceuticals announces hiring for Product Management Team
Responsible for designing overall marketing and communication strategy of brands Good at Sales & Market data analysis. Must possess knowledge of product strategy, product launch
6 January 2026
Amneal Pharmaceuticals Walk-In Drive for MPharm, BPharm & MSc in Injectable Manufacturing & Packing
Looking for candidates with relevant experience in Injectable regulated plant for Manufacturing, & Packing Department at SEZ Matoda
6 January 2026
FDA nods first pediatric therapy for rare blood disorder aTTP

The U.S. Food and Drug Administration has approved Cablivi (caplacizumab-yhdp) for pediatric patients 12 years and older suffering from acquired thrombotic thrombocytopenic purpura (aTTP), marking the first time a treatment has been authorized for this extremely rare condition in children.

6 January 2026
ScinoPharm gets U.S. FDA approval for Multiple Sclerosis treatment
ScinoPharm Taiwan has clinched a landmark regulatory victory by securing U.S. Food and Drug Administration (FDA) approval for its Glatiramer Acetate Injection, a treatment used to manage multiple sclerosis (MS), the company announced
6 January 2026
Intas Pharma Walk-In Drive for Senior Executive and Executive Positions in IPQA, CQA, QC
B. Pharmacy/M. Pharmacy; Self Inspection Audit, Audit trail, Electronic data management, Qualification (Shift Working). Finished Products & Analytical Method Validation